Last reviewed · How we verify
von Willebrand disorder
Approved treatments
- Vonvendi · Baxalta US Inc.
- Minirin · Hormozgan University of Medical Sciences
- Ddavp · Ferring Pharms Inc
- Argipressin · Kristina Svennerholm
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- von Willebrand disorder patent landscape — cliff calendar, originator estates, attackable patents
- von Willebrand disorder treatment landscape brief
- von Willebrand disorder treatment updates RSS
Frequently asked questions about von Willebrand disorder
What drugs treat von Willebrand disorder?
Tracked treatments include Vonvendi, Minirin, Ddavp, Argipressin.
What is the treatment for von Willebrand disorder?
Standard treatment for von Willebrand disorder includes Vonvendi, Minirin, Ddavp, Argipressin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: von Willebrand disorder patent cliff · von Willebrand disorder CI report
- Treatment: Vonvendi · Baxalta US Inc.
- Treatment: Minirin · Hormozgan University of Medical Sciences
- Treatment: Ddavp · Ferring Pharms Inc
- Treatment: Argipressin · Kristina Svennerholm
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing